This page shows the publications co-authored by Anthony Lembo and Irving Kirsch.
Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial. Pain. 2021 09 01; 162(9):2428-2435.
Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2010 Dec 22; 5(12):e15591.
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ. 2008 May 03; 336(7651):999-1003.
Are they side effects? Extra-intestinal symptoms reported during clinical trials of IBS may be more severe at baseline. Clin Gastroenterol Hepatol. 2022 Mar 23.
Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Trials. 2017 05 25; 18(1):234.
Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients. Brain Behav. 2015 Jan; 5(1):39-44.
Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One. 2012; 7(10):e48135.
Patient and practitioner influences on the placebo effect in irritable bowel syndrome. Psychosom Med. 2009 Sep; 71(7):789-97.
Investigating placebo effects in irritable bowel syndrome: a novel research design. Contemp Clin Trials. 2006 Apr; 27(2):123-34.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.